Vanqua Bio is helping usher in a new era of hope for the millions of people living with neurodegenerative diseases. Our unique drug-development approach is designed to overcome longstanding challenges in the neuroscience field by capitalizing on the power of human genetics to identify genes that cause or increase the risk of neurodegenerative disease. We leverage novel, proprietary research tools and in vitro modeling of disease, based on patient-derived neuronal cells, to develop transformative therapies that slow or stop the progression of Parkinson’s disease (PD), Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Gaucher disease (GD). 

Biotechnology

Vanqua Bio

Vanqua Bio's headquarters in Chicago, IL, United States

Jim Sullivan

Jesse Cedarbaum

Jack Beyer

Bernard Davitian

Mona Ashiya

Sara Nayeem

Dimitri Krainc

James B. Summers

Gregory Grabowski

Jonathan Silverstein

Rand Sutherland

The Research and Development team at Vanqua Bio is dedicated to advancing innovative therapies for neurodegenerative diseases through cutting-edge drug discovery and development. This multidisciplinary team, comprising experts in cell and molecular pharmacology, medicinal chemistry, and scientific research, collaborates to identify and validate genetic targets, develop in vitro disease models, and ultimately translate scientific findings into transformative treatments for conditions like Parkinson’s, Alzheimer’s, ALS, and Gaucher disease.

Research and Development

The Leadership Team at Vanqua Bio is responsible for shaping the strategic direction of the company, guiding its mission to develop innovative therapies for neurodegenerative diseases. Comprising key executives, including the CEO, Chief Business Officer, and Chief Scientific Officer, this team collaborates to align research goals with business objectives, drives partnerships, and ensures that the company's groundbreaking approaches effectively address the challenges within the neuroscience field.

Leadership Team

The Research and Development Team at Vanqua Bio focuses on pioneering innovative therapies for neurodegenerative diseases by harnessing human genetic insights. Collaborating closely, team members design and execute experiments using proprietary research tools and patient-derived neuronal models to identify and validate drug targets, ultimately working towards groundbreaking solutions to slow or halt the progression of conditions such as Parkinson’s, Alzheimer’s, and ALS.

Vanqua Bio

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Research and Development Team

Offices

Vanqua Bio

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Research and Development Team

Offices

Related companies